Page last updated: 2024-10-28

glyburide and Idiopathic Parkinson Disease

glyburide has been researched along with Idiopathic Parkinson Disease in 2 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Brain samples from five patients with Huntington's disease were studied."1.29Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease. ( Agid, Y; De Paermentier, F; Holemans, S; Javoy-Agid, F; Laterre, EC; Maloteaux, JM, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tai, KK1
Truong, DD1
Holemans, S1
Javoy-Agid, F1
Agid, Y1
De Paermentier, F1
Laterre, EC1
Maloteaux, JM1

Other Studies

2 other studies available for glyburide and Idiopathic Parkinson Disease

ArticleYear
Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
    Journal of neuroscience research, 2002, Aug-15, Volume: 69, Issue:4

    Topics: Adenosine Triphosphate; Animals; Cell Death; Dose-Response Relationship, Drug; Electron Transport Co

2002
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
    Brain research, 1994, Apr-11, Volume: 642, Issue:1-2

    Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Animals; ATP-Binding Cassette Transporters; Brain C

1994